Menu
Microsoft strongly encourages users to switch to a different browser than Internet Explorer as it no longer meets modern web and security standards. Therefore we cannot guarantee that our site fully works in Internet Explorer. You can use Chrome or Firefox instead.

Predictions

buy
AT&T Inc..

Start price
Target price
Perf. (%)
€21.95
23.12.21
-
23.12.22
-16.80%
16.11.22

buy
Gamestop Corp.

Start price
Target price
Perf. (%)
€32.81
15.12.21
-
15.12.22
-21.04%
16.11.22

buy
BASF SE

Start price
Target price
Perf. (%)
€59.80
03.12.21
-
03.12.22
-16.67%
16.11.22

buy
K+S AG

Start price
Target price
Perf. (%)
€14.65
27.11.21
-
27.11.22
49.47%
16.11.22

buy
Meta Platforms Inc.

Start price
Target price
Perf. (%)
€303.60
17.11.21
-
17.11.22
-62.82%
16.11.22

Axsome Therapeutics Inc

Start price
Target price
Perf. (%)
€32.27
16.11.21
€25.00
16.11.22
59.84%
16.11.22

Could be very worthwhile Investment >20% year
Capsensixx AG

Start price
Target price
Perf. (%)
€15.50
15.11.21
€11.00
15.11.22
0.65%
16.11.22

Probably not worthwhile Investment
overvalued
Outdated or very high risk business model
Very high cyclical dependencies
buy
Artnet AG NA

Start price
Target price
Perf. (%)
€9.70
15.11.21
€9.00
15.11.22
-31.96%
16.11.22

Could be very worthwhile Investment >20% year
Undervalued
Very good company culture
Leading role in innovation
buy
Tilray Inc

Start price
Target price
Perf. (%)
€7.23
06.04.22
€10.00
06.04.23
-42.73%
15.11.22

Could be worthwhile Investment >10% per year
buy
Agrogeneration

Start price
Target price
Perf. (%)
€0.13
16.03.22
€0.20
16.03.23
-39.21%
15.11.22

Could be worthwhile Investment >10% per year
buy
Alphabet Inc. C

Start price
Target price
Perf. (%)
€106.02
15.09.22
€115.00
15.11.22
-11.96%
15.11.22

Pilbara Minerals Ltd

Start price
Target price
Perf. (%)
€1.57
15.11.21
-
15.11.22
102.23%
15.11.22

Could be very worthwhile Investment >20% year
Revenue growth > 30% per year expected
buy
Bolt Biotherapeutics Inc.

Start price
Target price
Perf. (%)
€8.95
14.11.21
€13.00
14.11.22
-85.47%
15.11.22

Could be worthwhile Investment >10% per year
buy
BioNTech SE ADR

Start price
Target price
Perf. (%)
€210.00
14.11.21
€185.00
14.11.22
-25.98%
15.11.22

EBIT growth > 30% per year expected
Higher EBIT margin than peer group
Fair valuation
Higher risks for its business
buy
Nel ASA

Start price
Target price
Perf. (%)
€2.04
14.11.21
€2.10
14.11.22
-33.78%
15.11.22

Innovative
Future proof or reliable business model
Well known brand
No uniques
buy
Ballard Power Systems Inc.

Start price
Target price
Perf. (%)
€16.30
14.11.21
€10.00
14.11.22
-62.67%
15.11.22

Could be worthwhile Investment >10% per year
Standard Investments for future growth
Revenue growth >5% per year expected
ROE lower than 10% per year
Oatly Group Ab

Start price
Target price
Perf. (%)
€10.80
14.11.21
€6.00
14.11.22
-80.56%
15.11.22

Consus Real Estate AG

Start price
Target price
Perf. (%)
€1.51
14.11.21
-
14.11.22
-75.79%
15.11.22

Risky Investment
Exasol AG

Start price
Target price
Perf. (%)
€7.12
14.11.21
-
14.11.22
-55.06%
15.11.22

Risky Investment
Curis Inc.

Start price
Target price
Perf. (%)
€5.06
14.11.21
-
14.11.22
-83.10%
15.11.22

Probably not worthwhile Investment
Can-Fite BioPharma Ltd.

Start price
Target price
Perf. (%)
€11.60
14.11.21
-
14.11.22
-33.62%
15.11.22

Probably not worthwhile Investment
buy
Pharmaron Beijing Co. Ltd.

Start price
Target price
Perf. (%)
€3.80
01.11.22
-
01.11.23
40.79%
15.11.22

Could be worthwhile Investment >10% per year
buy
ShiftPixy Inc.

Start price
Target price
Perf. (%)
€12.20
18.10.22
-
18.10.23
72.13%
15.11.22

Revenue growth >5% per year expected
EBIT growth >5% per year expected
Probably not worthwhile Investment
Lower EBIT Margin than peer group
buy
Longfor Group Holdings Limited

Start price
Target price
Perf. (%)
€1.35
01.11.22
-
01.11.23
88.15%
15.11.22

Could be worthwhile Investment >10% per year
BICO Group AB

Start price
Target price
Perf. (%)
€3.13
03.09.22
-
03.09.23
171.89%
14.11.22

Could be worthwhile Investment >10% per year